Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia

The uncertainty could be examined through sequential analysis, reflecting the methodology utilized in the original synthesis—a crucial approach proficient in controlling both Type I and Type II error rates in analyses, ensuring statistical robustness before reaching the required information size [3]...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care (London, England) England), 2024-02, Vol.28 (1), p.55-55, Article 55
Hauptverfasser: Lu, De-En, Chang, Cheng-Yi, Cheng, Sheng-Wei, Kang, Enoch, Lee, Chih-Hsin, Chen, Kee-Hsin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 55
container_issue 1
container_start_page 55
container_title Critical care (London, England)
container_volume 28
creator Lu, De-En
Chang, Cheng-Yi
Cheng, Sheng-Wei
Kang, Enoch
Lee, Chih-Hsin
Chen, Kee-Hsin
description The uncertainty could be examined through sequential analysis, reflecting the methodology utilized in the original synthesis—a crucial approach proficient in controlling both Type I and Type II error rates in analyses, ensuring statistical robustness before reaching the required information size [3]. [...]this correspondence would like to provide evidence to fulfill the information gap by sequential analysis. The result of sequential analysis for the non-hydrocortisone subgroup should be interpreted cautiously, as the current evidence remains inconclusive. [...]clinicians and researchers gain a more comprehensive understanding and evidence regarding the efficacy of steroids other than hydrocortisone in treating severe CAP, it is prudent to consider hydrocortisone as a viable recommendation for the management of patients with CAP. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials.
doi_str_mv 10.1186/s13054-024-04833-2
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10880276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A783378374</galeid><sourcerecordid>A783378374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-d8ee8d9af7af94b30eb817a176afd61414e88a10439199c482a294e1d26dd153</originalsourceid><addsrcrecordid>eNptUk1rFTEUDaLYWv0DLmTAjZup-Zp8rKSU-gEFN12Im5CX3PSlzCTTZKby_r15vlqtSLgk3Jxzcu_NQeg1waeEKPG-EoYH3mPagivGevoEHRMuRC-w_va0nZngvRrYcIRe1HqDMZFKsOfoiCkm1aDwMfp-cRc9JAddXec5l6V2yxa6tUKXQ7fd-ZJdy8aaE3Qhl262S4TUYD_isu1cnqY1xWXXW3e7xgK-mxOsU07RvkTPgh0rvLrfT9DVx4ur88_95ddPX87PLnvHuV56rwCU1zZIGzTfMAwbRaQlUtjgBeGEg1KWYM400dpxRS3VHIinwnsysBP04SA7r5sJvGvFFTuaucTJlp3JNprHNyluzXW-MwQrhakUTeHdvULJtyvUxUyxOhhHmyCv1VBN9cCUHEiDvv0HepPXklp7DTUI1dQU_YO6tiOYmEJuD7u9qDmT7aNaSN5Qp_9BteVhiq7NO8SWf0SgB4IrudYC4aFJgs3eEebgCNMcYX45wuxrefP3eB4ovy3AfgI2X7Ic</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2956876382</pqid></control><display><type>article</type><title>Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA Free Journals</source><creator>Lu, De-En ; Chang, Cheng-Yi ; Cheng, Sheng-Wei ; Kang, Enoch ; Lee, Chih-Hsin ; Chen, Kee-Hsin</creator><creatorcontrib>Lu, De-En ; Chang, Cheng-Yi ; Cheng, Sheng-Wei ; Kang, Enoch ; Lee, Chih-Hsin ; Chen, Kee-Hsin</creatorcontrib><description>The uncertainty could be examined through sequential analysis, reflecting the methodology utilized in the original synthesis—a crucial approach proficient in controlling both Type I and Type II error rates in analyses, ensuring statistical robustness before reaching the required information size [3]. [...]this correspondence would like to provide evidence to fulfill the information gap by sequential analysis. The result of sequential analysis for the non-hydrocortisone subgroup should be interpreted cautiously, as the current evidence remains inconclusive. [...]clinicians and researchers gain a more comprehensive understanding and evidence regarding the efficacy of steroids other than hydrocortisone in treating severe CAP, it is prudent to consider hydrocortisone as a viable recommendation for the management of patients with CAP. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials.</description><identifier>ISSN: 1364-8535</identifier><identifier>EISSN: 1466-609X</identifier><identifier>EISSN: 1364-8535</identifier><identifier>EISSN: 1366-609X</identifier><identifier>DOI: 10.1186/s13054-024-04833-2</identifier><identifier>PMID: 38378580</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Community-Acquired Infections - drug therapy ; Correspondence ; Humans ; Hydrocortisone - therapeutic use ; Mortality ; Pneumonia ; Pneumonia - drug therapy ; Standard scores ; Steroids</subject><ispartof>Critical care (London, England), 2024-02, Vol.28 (1), p.55-55, Article 55</ispartof><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c449t-d8ee8d9af7af94b30eb817a176afd61414e88a10439199c482a294e1d26dd153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880276/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10880276/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38378580$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, De-En</creatorcontrib><creatorcontrib>Chang, Cheng-Yi</creatorcontrib><creatorcontrib>Cheng, Sheng-Wei</creatorcontrib><creatorcontrib>Kang, Enoch</creatorcontrib><creatorcontrib>Lee, Chih-Hsin</creatorcontrib><creatorcontrib>Chen, Kee-Hsin</creatorcontrib><title>Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia</title><title>Critical care (London, England)</title><addtitle>Crit Care</addtitle><description>The uncertainty could be examined through sequential analysis, reflecting the methodology utilized in the original synthesis—a crucial approach proficient in controlling both Type I and Type II error rates in analyses, ensuring statistical robustness before reaching the required information size [3]. [...]this correspondence would like to provide evidence to fulfill the information gap by sequential analysis. The result of sequential analysis for the non-hydrocortisone subgroup should be interpreted cautiously, as the current evidence remains inconclusive. [...]clinicians and researchers gain a more comprehensive understanding and evidence regarding the efficacy of steroids other than hydrocortisone in treating severe CAP, it is prudent to consider hydrocortisone as a viable recommendation for the management of patients with CAP. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials.</description><subject>Community-Acquired Infections - drug therapy</subject><subject>Correspondence</subject><subject>Humans</subject><subject>Hydrocortisone - therapeutic use</subject><subject>Mortality</subject><subject>Pneumonia</subject><subject>Pneumonia - drug therapy</subject><subject>Standard scores</subject><subject>Steroids</subject><issn>1364-8535</issn><issn>1466-609X</issn><issn>1364-8535</issn><issn>1366-609X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptUk1rFTEUDaLYWv0DLmTAjZup-Zp8rKSU-gEFN12Im5CX3PSlzCTTZKby_r15vlqtSLgk3Jxzcu_NQeg1waeEKPG-EoYH3mPagivGevoEHRMuRC-w_va0nZngvRrYcIRe1HqDMZFKsOfoiCkm1aDwMfp-cRc9JAddXec5l6V2yxa6tUKXQ7fd-ZJdy8aaE3Qhl262S4TUYD_isu1cnqY1xWXXW3e7xgK-mxOsU07RvkTPgh0rvLrfT9DVx4ur88_95ddPX87PLnvHuV56rwCU1zZIGzTfMAwbRaQlUtjgBeGEg1KWYM400dpxRS3VHIinwnsysBP04SA7r5sJvGvFFTuaucTJlp3JNprHNyluzXW-MwQrhakUTeHdvULJtyvUxUyxOhhHmyCv1VBN9cCUHEiDvv0HepPXklp7DTUI1dQU_YO6tiOYmEJuD7u9qDmT7aNaSN5Qp_9BteVhiq7NO8SWf0SgB4IrudYC4aFJgs3eEebgCNMcYX45wuxrefP3eB4ovy3AfgI2X7Ic</recordid><startdate>20240220</startdate><enddate>20240220</enddate><creator>Lu, De-En</creator><creator>Chang, Cheng-Yi</creator><creator>Cheng, Sheng-Wei</creator><creator>Kang, Enoch</creator><creator>Lee, Chih-Hsin</creator><creator>Chen, Kee-Hsin</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240220</creationdate><title>Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia</title><author>Lu, De-En ; Chang, Cheng-Yi ; Cheng, Sheng-Wei ; Kang, Enoch ; Lee, Chih-Hsin ; Chen, Kee-Hsin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-d8ee8d9af7af94b30eb817a176afd61414e88a10439199c482a294e1d26dd153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Community-Acquired Infections - drug therapy</topic><topic>Correspondence</topic><topic>Humans</topic><topic>Hydrocortisone - therapeutic use</topic><topic>Mortality</topic><topic>Pneumonia</topic><topic>Pneumonia - drug therapy</topic><topic>Standard scores</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, De-En</creatorcontrib><creatorcontrib>Chang, Cheng-Yi</creatorcontrib><creatorcontrib>Cheng, Sheng-Wei</creatorcontrib><creatorcontrib>Kang, Enoch</creatorcontrib><creatorcontrib>Lee, Chih-Hsin</creatorcontrib><creatorcontrib>Chen, Kee-Hsin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Critical care (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, De-En</au><au>Chang, Cheng-Yi</au><au>Cheng, Sheng-Wei</au><au>Kang, Enoch</au><au>Lee, Chih-Hsin</au><au>Chen, Kee-Hsin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia</atitle><jtitle>Critical care (London, England)</jtitle><addtitle>Crit Care</addtitle><date>2024-02-20</date><risdate>2024</risdate><volume>28</volume><issue>1</issue><spage>55</spage><epage>55</epage><pages>55-55</pages><artnum>55</artnum><issn>1364-8535</issn><eissn>1466-609X</eissn><eissn>1364-8535</eissn><eissn>1366-609X</eissn><abstract>The uncertainty could be examined through sequential analysis, reflecting the methodology utilized in the original synthesis—a crucial approach proficient in controlling both Type I and Type II error rates in analyses, ensuring statistical robustness before reaching the required information size [3]. [...]this correspondence would like to provide evidence to fulfill the information gap by sequential analysis. The result of sequential analysis for the non-hydrocortisone subgroup should be interpreted cautiously, as the current evidence remains inconclusive. [...]clinicians and researchers gain a more comprehensive understanding and evidence regarding the efficacy of steroids other than hydrocortisone in treating severe CAP, it is prudent to consider hydrocortisone as a viable recommendation for the management of patients with CAP. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38378580</pmid><doi>10.1186/s13054-024-04833-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1364-8535
ispartof Critical care (London, England), 2024-02, Vol.28 (1), p.55-55, Article 55
issn 1364-8535
1466-609X
1364-8535
1366-609X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10880276
source MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA Free Journals
subjects Community-Acquired Infections - drug therapy
Correspondence
Humans
Hydrocortisone - therapeutic use
Mortality
Pneumonia
Pneumonia - drug therapy
Standard scores
Steroids
title Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A08%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20supports%20the%20use%20of%20hydrocortisone%20for%20patients%20with%20community-acquired%20pneumonia&rft.jtitle=Critical%20care%20(London,%20England)&rft.au=Lu,%20De-En&rft.date=2024-02-20&rft.volume=28&rft.issue=1&rft.spage=55&rft.epage=55&rft.pages=55-55&rft.artnum=55&rft.issn=1364-8535&rft.eissn=1466-609X&rft_id=info:doi/10.1186/s13054-024-04833-2&rft_dat=%3Cgale_pubme%3EA783378374%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2956876382&rft_id=info:pmid/38378580&rft_galeid=A783378374&rfr_iscdi=true